Gene-specific methylation: Potential markers for colorectal cancer

International Journal of Biological Markers

Volumn 24, Issue 1, 2009, Pages 57-62

  Prabhu, Jyothi S ^a   Korlimarla, Aruna ^a   Banerjee, Arindam ^a   Wani, Shivangi ^a   Payal, K ^a   Sahoo, Rashmita ^a,b  

^a Triesta Sciences (I) Private Limited   (India)

^b Triesta Sciences   (India)

Author keywords

Colorectal cancer; Gene expression; Methylation; Promoter methylation

Indexed keywords

PROTEIN MLH1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SECRETED FRIZZLED RELATED PROTEIN 1; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1OD; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DIAGNOSTIC ACCURACY; DNA REPAIR; GENE EXPRESSION; GENE SILENCING; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; ONCOGENE; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN METHYLATION; SIGNAL TRANSDUCTION;

EID: 67649983235     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2009.3486     Document Type: Article

References (17)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 8-31.
2. Markowitz SD, Dawson DM, Willis J, Willson JKV. Focus on colon cancer. Cancer Cell 2002; 1: 233-6.
3. Pretlow TP, Barrow BJ, Ashton WS, et al. Aberrant crypt foci: Putative preneoplastic foci in human colonic mucosa. Cancer Res 1991; 51: 1564-7.
4. Itzkowitz SH, Xianyang Y. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004; 287: G7-17.
5. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-32
6. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997; 386: 623-7.
7. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681-6.
8. Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Bronner MP, Brentnall TA. The initiation of colon cancer in a chronic inflammatory setting. Carcinogenesis 2005; 9: 1513-9.
9. Cheng Y, Desreumaux P. 5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease. World J Gastroenterol 2005; 11: 309-14.
10. Cronin M, Mylan P, Dutta D, et al. Measurement of gene expression in archival paraffin embedded tissues. Am J Pathol 2004; 164: 35-42.
11. Umetani N, de Maat MF, Sunami E, Hiramatsu S, Martinez S, Hoon DS. Methylation of p16 and ras association domain family protein 1a during colorectal malignant transformation. Mol Cancer Res 2006; 4: 303-9.
12. Fatemi M, Pao MM, Jeong S, et al. Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level. Nucleic Acids Res 2005; 33: e176.
13. Wagner KJ, Cooper WN, Grundy RG, et al. Frequent RASSF1A tumor suppressor gene promoter methylations in Wilms' tumour and colorectal cancer. Oncogene 2002; 21: 7277-82.
14. Grady WM, Rajput A, Lutterbaugh JD, Markowitz SD. Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res 2001; 61: 900-2.
15. Qi J, Zhu YQ, Luo J, Tao WH. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol 2006; 12: 7113-7.
16. Toyota M, Ahuja N, Toyota MO, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681-6.
17. Eliceiri BP, Poul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 1999; 4: 915-24.